New hope against superbug: triple therapy trial launches
NCT ID NCT06440304
First seen Jan 27, 2026 · Last updated Jun 05, 2026 · Updated 18 times
Summary
This study tests three different antibiotic combinations to treat a dangerous, drug-resistant infection (CRAB) in intensive care patients. About 108 adults who had surgery and are now in the ICU with a CRAB infection will be randomly assigned to one of three combos. The goal is to find which mix clears the infection fastest, improves survival, and reduces hospital stays.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIONS, BACTERIAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Centre Zagreb
RECRUITINGZagreb, 10000, Croatia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.